Phibro Animal Health Corp. A Stock
Phibro Animal Health Corp. A gained 1.920% today.
The community is currently still undecided about Phibro Animal Health Corp. A with 1 Buy predictions and 1 Sell predictions.
As a result the target price of 33 € shows a slightly positive potential of 3.77% compared to the current price of 31.8 € for Phibro Animal Health Corp. A.
Pros and Cons of Phibro Animal Health Corp. A in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Phibro Animal Health Corp. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Phibro Animal Health Corp. A | 1.920% | 3.247% | 10.417% | 41.964% | 0.633% | 137.313% | 55.882% |
| Pacira Pharmaceuticals | 0.860% | 0.000% | 5.405% | 19.388% | 8.333% | -33.143% | -53.200% |
| Corcept Therapeutics Inc. | -1.800% | 15.059% | 21.989% | 53.499% | 39.222% | 235.211% | 423.077% |
| Supernus Pharmaceuticals | 14.510% | 10.500% | 5.742% | 45.395% | 2.791% | 52.414% | 95.575% |
Comments
Phibro Animal Health (NASDAQ:PAHC) had its price target raised by analysts at JPMorgan Chase & Co. from $45.00 to $50.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PAHC provided by MarketBeat
Phibro Animal Health (NASDAQ:PAHC) had its price target raised by analysts at Bank of America Corporation from $19.00 to $27.00. They now have an "underperform" rating on the stock.
Show more
Ratings data for PAHC provided by MarketBeat
Phibro Animal Health Corporation (NASDAQ: PAHC) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $35.00 price target on the stock, up previously from $25.00.
Show more
Ratings data for PAHC provided by MarketBeat